Petros Pharmaceuticals Inc financial statements
Petros Pharmaceuticals Inc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Net income | USD 1.91M | 10-K |
| Cash and equivalents | USD 5.14M | 10-Q |
Petros Pharmaceuticals Inc financials on 6ix · Petros Pharmaceuticals Inc on 6ix